TherapeuticsMD (TXMD) Revenue (2011 - 2026)
TherapeuticsMD's Revenue was $869,000 in Q2 2026, down 8.7% from $952,000 a year earlier but up 20.0% from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) Revenue (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, TherapeuticsMD's Revenue was $3.27 million through Jun 30, 2026, up 27.8% year-over-year; for FY2025, it was $3.02 million, up 71.6% from FY2024.
- Revenue shows a five-year compound annual growth rate of -45.8% (FY2020 to FY2025).
- In earlier years, Revenue was $1.76 million in FY2024 (+35.3%), $1.3 million in FY2023 (-98.1%), $69.96 million in FY2022 and $2.57 million in FY2021 (-96.0%).
- Quarterly Revenue has moved between $53,000 (Q3 2023) and $68.57 million (Q4 2022) over five years.
- Compared with a year earlier, Revenue was higher in seven of the last eight quarters, with growth averaging 181.3%.
- The best year-over-year quarter for Revenue over five years was Q3 2024 (growth of 932.1%); the worst was Q4 2023 (a decline of 99.3%).
- Per Business Quant data, TXMD's Revenue in the three quarters before Q2 2026 was $724,000 (Q1 2026), $893,000 (Q4 2025) and $784,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | TherapeuticsMD | 24.19 Mn | 24.19 Mn | - | 869,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 869,000.00 |
| Mar 31, 2026 | 724,000.00 |
| Dec 31, 2025 | 893,000.00 |
| Sep 30, 2025 | 784,000.00 |
| Jun 30, 2025 | 952,000.00 |
| Mar 31, 2025 | 393,000.00 |
| Dec 31, 2024 | 667,000.00 |
| Sep 30, 2024 | 547,000.00 |
| Jun 30, 2024 | 234,000.00 |
| Mar 31, 2024 | 313,000.00 |
| Dec 31, 2023 | 502,000.00 |
| Sep 30, 2023 | 53,000.00 |
| Jun 30, 2023 | 437,000.00 |
| Mar 31, 2023 | 416,000.00 |
| Dec 31, 2022 | 68.57 Mn |
| Sep 30, 2022 | 354,000.00 |
| Jun 30, 2022 | 348,000.00 |
| Mar 31, 2022 | 695,000.00 |
| Dec 31, 2021 | 18.68 Mn |
| Sep 30, 2021 | 25.41 Mn |
API Access
TherapeuticsMD Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();